Table 2.
The antibodies against measles, mumps and rubella by age group in the measles outbreak, May–October 2018, the Michalovce and Sobrance districts in the Košice region, Slovakia (n=102).
| Positive and cut-off values (n=102) (%) |
|||||||
|---|---|---|---|---|---|---|---|
| Characteristic | 0 | 1-4 | 5-9 | 10-14 | 15-19 | 20-24 | 25-34 |
| All cases | 23 | 45 | 12 | 13 | 7 | 2 | 102 |
| MEASLES | |||||||
| IgM n=68 | 13 (12.7) | 31 (30.4) | 8 (7.8) | 11 (10.8) | 4 (3.9) | 1 (1.0) | 68 (66.7) |
| IgG n=23 | 1 (1.0) | 7 (6.9) | 3 (2.9) | 4 (3.9) | 6 (5.9) | 2 (2.0) | 23 (22.5) |
| MUMPS | |||||||
| IgG n=60 | 10 (9.8) | 28 (27.5) | 8 (7.8) | 6 (5.9) | 6 (5.9) | 2 (2.0) | 60 (58.8) |
| RUBELLA | |||||||
| IgG n=20 | 2 (2.0) | 3 (2.9) | 3 (2.9) | 4 (3.9) | 6 (5.9) | 2 (2.0) | 20 (19.6) |
| Positive antibodies against rubella and the type of applied combination vaccines (n=20) (%) | |||||||
| MMR+MMR | 2 (10.0) | 3 (15.0) | 3 (15.0) | 1 (5.0) | 0 | 0 | 9 (45.0) |
| MM+MMR | 0 | 0 | 0 | 3 (15.0) | 1 (5.0) | 0 | 4 (20.0) |
| Mo+Mo | 0 | 0 | 0 | 0 | 5 (25.0) | 2 (10.0) | 7 (35.0) |
| TOTAL | 2 (10.0) | 3 (15.0) | 3 (15.0) | 4 (20.0) | 6 (30.0) | 2 (10.0) | 20 (100.0) |
| Negative antibodies against rubella and the type of applied combination vaccines (n=82) (%) | |||||||
| MMR+MMR* | 21 (25.6) | 42 (51.2) | 9 (11.0) | 9 (11.0) | 0 | 0 | 81 (98.8) |
| MM+MMR** | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mo+Mo*** | 0 | 0 | 0 | 0 | 1 (1.2) | 0 | 1 (1.2) |
| TOTAL | 21 (25.6) | 42 (51.2) | 9 (11.0) | 9 (11.0) | 1 (1.2) | 0 | 82 (100.0) |
*
MMR+MMR: two doses of trivalent vaccine against measles, mumps and rubella
**
MM+MMR: one dose of bivalent measles-mumps vaccine, and one dose of trivalent measles-mumps-rubella vaccine
***
Mo+Mo: two doses of monovalent vaccine against measles